- Home
- MCRB vs MRT Comparison
MCRB vs MRT Comparison
Compare MCRB & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- MRT
- Stock Information
- Founded
- MCRB 2010
- MRT 2018
- Country
- MCRB United States
- MRT Turkey
- Employees
- MCRB N/A
- MRT N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- MRT Rental/Leasing Companies
- Sector
- MCRB Health Care
- MRT Consumer Discretionary
- Exchange
- MCRB Nasdaq
- MRT Nasdaq
- Market Cap
- MCRB 156.3M
- MRT 117.0M
- IPO Year
- MCRB 2015
- MRT N/A
- Fundamental
- Price
- MCRB $0.84
- MRT $3.36
- Analyst Decision
- MCRB Buy
- MRT
- Analyst Count
- MCRB 4
- MRT 0
- Target Price
- MCRB $5.63
- MRT N/A
- AVG Volume (30 Days)
- MCRB 2.4M
- MRT 62.8K
- Earning Date
- MCRB 11-13-2024
- MRT 01-01-0001
- Dividend Yield
- MCRB N/A
- MRT N/A
- EPS Growth
- MCRB N/A
- MRT N/A
- EPS
- MCRB N/A
- MRT N/A
- Revenue
- MCRB $126,325,000.00
- MRT $18,953,502.00
- Revenue This Year
- MCRB N/A
- MRT N/A
- Revenue Next Year
- MCRB N/A
- MRT N/A
- P/E Ratio
- MCRB N/A
- MRT N/A
- Revenue Growth
- MCRB 12856.41
- MRT N/A
- 52 Week Low
- MCRB $0.54
- MRT $0.62
- 52 Week High
- MCRB $2.05
- MRT $3.55
- Technical
- Relative Strength Index (RSI)
- MCRB 47.60
- MRT 60.11
- Support Level
- MCRB $0.80
- MRT $3.11
- Resistance Level
- MCRB $1.00
- MRT $3.50
- Average True Range (ATR)
- MCRB 0.06
- MRT 0.26
- MACD
- MCRB -0.01
- MRT -0.01
- Stochastic Oscillator
- MCRB 20.46
- MRT 81.08
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, operating a fleet of over 48,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.